Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Archives of Iranian MedicineOpen Access

Prognostic Analysis of VEGF, CRP and Contrast-Enhanced Ultrasound Combined with Interventional Embolization for Primary Liver Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ZDZheng DongKTKehui TongYWYingjie Wu

Discussion

Loading...

Member takes

Overview

Prognostic analysis shows CRP and vascular endothelial growth factor impact progression-free survival in liver cancer patients post-embolic therapy.

Key Points

  • This research examines the prognostic significance of specific biomarkers and imaging techniques in liver cancer treatment.
  • Evaluated 277 patients undergoing hepatic arterial chemoembolization for liver cancer.
  • Measured C-reactive protein and vascular endothelial growth factor before interventional therapy.
  • Utilized contrast-enhanced ultrasound to assess tumor characteristics and monitor progression.
  • Identified crucial correlations between C-reactive protein and vascular endothelial growth factor levels with disease outcomes.
  • Contrast-enhanced ultrasound data provided insights into tumor progression dynamics.
  • Progression-free survival rates were influenced by pre-treatment biomarker levels.

Cite This Study

Dong et al. (2025) studied this question.

synapsesocial.com/papers/69254f97c0ce034ddc359f74https://doi.org/10.34172/aim.34648
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer2025
  2. 2Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinoma2026
  3. 3Early prediction of response to chemotherapy with Cetuximab in colorectal liver metastasis with contrast-enhanced ultrasound perfusion analysis2026
  4. 4Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma post Transcatheter Arterial Chemoembolization 2024 · 1 citations
  5. 5Efficacy of TACE combined with targeted immunotherapy in the treatment of advanced liver cancer2026